Is it time to go bargain hunting in the aged care sector?

Or "Why I wouldn't touch Japara Healthcare Ltd (ASX:JHC), Estia Health Ltd (ASX:EHE), and Regis Healthcare Ltd (ASX:REG) with a barge pole".

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Aged care providers have been sold off heavily in recent months following a government review of its Aged Care Funding Instrument ("ACFI"; a government subsidy) as well as Estia Health Ltd's (ASX: EHE) recently publicised earnings downgrade.

Given the long-term tailwinds of the industry, as well as the attractive funding made available through the Refundable Accommodation Deposit (RAD) system, aged care providers should be sitting pretty. Unfortunately they're not, due to high levels of debt, aggressive use of RADs to fund highly priced acquisitions, and vulnerability to government pressure on fees.

Estia Health in particular looks like trouble, and I would encourage investors to steer clear of this one entirely. The recent departure of its managerial team combined with high debt and the recent earnings downgrade should be considered strong warning signs. New management is moving in the right direction, but there could easily be 'more cockroaches in the kitchen'. In Estia's favour, it claims a lower error rate on its ACFI documentation of 1 in 14, below the industry average (more on this below). I could not find a recent instance of Japara or Regis reporting these figures.

Japara Healthcare Ltd (ASX: JHC) is my preference, thanks to its mixed status as both an aged care facility and retirement village operator. It also carries significantly less debt than Estia and appears to have been less aggressively run, with some of its acquisitions carrying a lower cost per bed than those made by similar businesses. Japara appears cheaper, while unlike Regis and Estia it also has a positive Net Tangible Asset (NTA) value of ~25 cents per share. In other words, its assets are worth more than its liabilities should the company be liquidated.

Regis Healthcare Ltd (ASX: REG) carries a higher level of debt, and its liabilities are valued at more than its tangible assets. After recent share price reversals in the sector, Regis is now the company with the highest apparent price tag although it also has significantly better operating cash flows than its two competitors (even if we exclude the RAD benefit, which is reported as 'operating' cash flows for some reason). With a higher price and higher leverage, it's less suitable than Japara, but also appears less risky than Estia.

The problem with the aged care sector

I think the sector as a whole has been run too aggressively. Management teams have gone wild with their RAD funding and bought everything that could have a price tag slapped on it. ACFI subsidies also appear to have been abused, with % growth rates in these per resident well above the indexation applied by the Commonwealth. The government has specifically stated that the increase in ACFI fees is well above its budget, and 'cannot be explained by increased frailty of residents'.

The amount of errors in the sector for ACFI documentation is also rising, currently 1 in 7 (~14%) in 2015-2016, up from 1 in 8 (~12%) in the prior year. This is a high error rate – by contrast, approximately 3% of taxpayers were contacted by the ATO regarding errors on their tax return (a similarly complex documentation task) in 2014.

As a result, investors should demand a higher margin of safety in their investment than they're getting at current prices. Japara remains my favourite for reasons listed above, but as a result of the myriad risks facing the sector, I'm not interested in any of the above companies at today's prices.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »